Halliburton Company

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

Halliburton (NYSE:HAL) Stock Rating Lowered by Wall Street Zen

AI-generated analysis

πŸ“‰ Wall Street Zen downgraded Halliburton from 'buy' to 'hold', contrasting with upgrades from Freedom Capital and Rothschild & Co.

πŸ’° Q2 earnings beat consensus estimates with $0.55 EPS and revenue of $5.71 billion, up 3.7% year-over-year.

πŸ“ˆ Net margin improved to 7.16% while return on equity reached 18.71% during the reported quarter.

🏦 Capital Research Global Investors increased its stake by 21.1%, now holding over $3.1 billion in shares.

πŸ“‰ EVP Van H. Beckwith sold 198,349 shares representing a 57.57% decrease in his personal position.

πŸ“Š Analyst consensus remains 'Moderate Buy' with an average price target of $43.14 across eighteen analysts.

🏒 Institutional ownership is high at 85.23%, with Morgan Stanley and Charles Schwab also increasing holdings.

Bullish Signals
  • Halliburton beat quarterly earnings expectations with EPS of $0.55 compared to the consensus estimate of $0.54.
  • Revenue grew by 3.7% year-over-year to reach $5.71 billion, demonstrating solid top-line performance.
  • Major institutional investors including Capital Research Global Investors and State Street Corp increased their stakes in the fourth quarter.
  • Rothschild & Co raised its price objective from $40.00 to $49.00 and maintained a 'buy' rating.
  • Capital One Financial upgraded its target price to $50.00 with an 'overweight' rating.
Risk Factors
  • Wall Street Zen downgraded the stock from 'buy' to 'hold', signaling potential caution regarding current valuation or outlook.
  • Executive insiders Van H. Beckwith and Eric Carre sold a combined total of over $9 million in shares under pre-arranged trading plans.
Full Analysis
Halliburton (NYSE:HAL) received a rating downgrade from 'buy' to 'hold' by Wall Street Zen, though other analysts maintain bullish or neutral stances with target prices ranging from $31.00 to $50.00. The consensus rating remains 'Moderate Buy' with an average price target of $43.14 based on data from MarketBeat.com. The company reported quarterly earnings on July 21st, beating analyst expectations with EPS of $0.55 versus a consensus of $0.54. Revenue reached $5.71 billion, representing a 3.7% year-over-year increase, while net margins stood at 7.16% and return on equity was 18.71%. Analysts forecast full-year EPS of $2.36. Insider activity saw significant selling from executives Van H. Beckwith and Eric Carre, who sold shares under pre-arranged Rule 10b5-1 trading plans, totaling over $9 million in recent transactions. Conversely, major institutional investors like Capital Research Global Investors and State Street Corp increased their stakes during the fourth quarter, indicating continued institutional confidence despite insider offloading.